Andreas Stadlbauer1,2, Max Zimmermann1, Arnd Doerfler3, Stefan Oberndorfer4, Michael Buchfelder1, Roland Coras5, Melitta Kitzwögerer6, Karl Roessler1. 1. Department of Neurosurgery, University of Erlangen-Nürnberg, Erlangen, Germany. 2. Institute of Medical Radiology, University Clinic of St Pölten, St Pölten, Austria. 3. Department of Neuroradiology, University of Erlangen-Nürnberg, Erlangen, Germany. 4. Department of Neurology, University Clinic of St Pölten, St Pölten, Austria. 5. Department of Neuropathology, University of Erlangen-Nürnberg, Erlangen, Germany. 6. Department of Pathology, University Clinic of St Pölten, St Pölten, Austria.
Abstract
Background: The intratumoral heterogeneity of oxygen metabolism in combination with variable patterns of neovascularization (NV) as well as reprogramming of energy metabolism affects the landscape of tumor microenvironments (TMEs) in glioblastoma. Knowledge of the hypoxic and perivascular niches within the TME is essential for understanding treatment failure. Methods: Fifty-two patients with untreated glioblastoma (isocitrate dehydrogenase 1 wild type [IDH1wt]) were examined with a physiological MRI protocol including a multiparametric quantitative blood oxygen level dependent (qBOLD) approach and vascular architecture mapping (VAM). Imaging biomarker information about oxygen metabolism (mitochondrial oxygen tension) and neovascularization (microvascular density and type) were fused for classification of 6 different TMEs: necrosis, hypoxia with/without neovascularization, oxidative phosphorylation (OxPhos), and glycolysis with/without neovascularization. Association of the different TME volume fractions with progression-free survival (PFS) was assessed using Kaplan-Meier analysis and Cox proportional hazards models. Results: A common spatial structure of TMEs was detected: central necrosis surrounded by tumor hypoxia (with defective and functional neovasculature) and different TMEs with a predominance of OxPhos and glycolysis for energy production, respectively. The percentage of the different TMEs on the total tumor volume uncovered 2 clearly different subtypes of glioblastoma IDH1wt: a glycolytic dominated phenotype with predominantly functional neovasculature and a necrotic/hypoxic dominated phenotype with approximately 50% of defective neovasculature. Patients with a necrotic/hypoxic dominated phenotype showed significantly shorter PFS (P = 0.035). Conclusions: Our non-invasive mapping approach allows for classification of the TME and detection of tumor-supportive niches in glioblastoma which may be helpful for both clinical patient management and research.
Background: The intratumoral heterogeneity of oxygen metabolism in combination with variable patterns of neovascularization (NV) as well as reprogramming of energy metabolism affects the landscape of tumor microenvironments (TMEs) in glioblastoma. Knowledge of the hypoxic and perivascular niches within the TME is essential for understanding treatment failure. Methods: Fifty-two patients with untreated glioblastoma (isocitrate dehydrogenase 1 wild type [IDH1wt]) were examined with a physiological MRI protocol including a multiparametric quantitative blood oxygen level dependent (qBOLD) approach and vascular architecture mapping (VAM). Imaging biomarker information about oxygen metabolism (mitochondrial oxygen tension) and neovascularization (microvascular density and type) were fused for classification of 6 different TMEs: necrosis, hypoxia with/without neovascularization, oxidative phosphorylation (OxPhos), and glycolysis with/without neovascularization. Association of the different TME volume fractions with progression-free survival (PFS) was assessed using Kaplan-Meier analysis and Cox proportional hazards models. Results: A common spatial structure of TMEs was detected: central necrosis surrounded by tumor hypoxia (with defective and functional neovasculature) and different TMEs with a predominance of OxPhos and glycolysis for energy production, respectively. The percentage of the different TMEs on the total tumor volume uncovered 2 clearly different subtypes of glioblastoma IDH1wt: a glycolytic dominated phenotype with predominantly functional neovasculature and a necrotic/hypoxic dominated phenotype with approximately 50% of defective neovasculature. Patients with a necrotic/hypoxic dominated phenotype showed significantly shorter PFS (P = 0.035). Conclusions: Our non-invasive mapping approach allows for classification of the TME and detection of tumor-supportive niches in glioblastoma which may be helpful for both clinical patient management and research.
Authors: D Ducreux; I Buvat; J F Meder; D Mikulis; A Crawley; D Fredy; K TerBrugge; P Lasjaunias; J Bittoun Journal: AJNR Am J Neuroradiol Date: 2006-05 Impact factor: 3.825
Authors: Eleonora Derlindati; Alessandra Dei Cas; Barbara Montanini; Valentina Spigoni; Valentina Curella; Raffaella Aldigeri; Diego Ardigò; Ivana Zavaroni; Riccardo C Bonadonna Journal: PLoS One Date: 2015-03-23 Impact factor: 3.240
Authors: Andreas Stadlbauer; Stefan Oberndorfer; Max Zimmermann; Bertold Renner; Michael Buchfelder; Gertraud Heinz; Arnd Doerfler; Andrea Kleindienst; Karl Roessler Journal: J Cereb Blood Flow Metab Date: 2019-02-07 Impact factor: 6.200
Authors: Andreas Stadlbauer; Thomas M Kinfe; Max Zimmermann; Ilker Eyüpoglu; Nadja Brandner; Michael Buchfelder; Moritz Zaiss; Arnd Dörfler; Sebastian Brandner Journal: J Cereb Blood Flow Metab Date: 2020-08-12 Impact factor: 6.200
Authors: Andreas Stadlbauer; Karl Roessler; Max Zimmermann; Michael Buchfelder; Andrea Kleindienst; Arnd Doerfler; Gertraud Heinz; Stefan Oberndorfer Journal: Mol Imaging Biol Date: 2019-08 Impact factor: 3.488
Authors: Vittorio Stumpo; Martina Sebök; Christiaan Hendrik Bas van Niftrik; Katharina Seystahl; Nicolin Hainc; Zsolt Kulcsar; Michael Weller; Luca Regli; Jorn Fierstra Journal: MAGMA Date: 2021-12-07 Impact factor: 2.310
Authors: Mikael T Erkkilä; David Reichert; Johanna Gesperger; Barbara Kiesel; Thomas Roetzer; Petra A Mercea; Wolfgang Drexler; Angelika Unterhuber; Rainer A Leitgeb; Adelheid Woehrer; Angelika Rueck; Marco Andreana; Georg Widhalm Journal: Sci Rep Date: 2020-11-24 Impact factor: 4.379
Authors: Gilbert Hangel; Cornelius Cadrien; Philipp Lazen; Julia Furtner; Alexandra Lipka; Eva Hečková; Lukas Hingerl; Stanislav Motyka; Stephan Gruber; Bernhard Strasser; Barbara Kiesel; Mario Mischkulnig; Matthias Preusser; Thomas Roetzer; Adelheid Wöhrer; Georg Widhalm; Karl Rössler; Siegfried Trattnig; Wolfgang Bogner Journal: Neuroimage Clin Date: 2020-09-15 Impact factor: 4.881